Checkmate Pharmaceuticals' Series B Round

Checkmate Pharmaceuticals raised a round of funding on June 15, 2017.

Checkmate Pharmaceuticals is a research and development company pursuing a novel approach to specifically activating the innate arm of the immune system to recognize and ultimately destroy tumor cells…

Articles about Checkmate Pharmaceuticals' Series B Round: